PMC Articles for MedGen (Select 925837) - PMC

Links from MedGen

Items: 1 to 20 of 572

<< First< Prev

Page of 29

Select item 56503311.

Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme

Sabrina Heynckes, Annette Gaebelein, Gerrit Haaker, Jürgen Grauvogel, Pamela Franco, Irina Mader, Maria Stella Carro, Marco Prinz, Daniel Delev, Oliver Schnell, Dieter Henrik Heiland

Oncotarget. 2017 Sep 26; 8(43): 74170–74177. Published online 2017 Jun 28. doi: 10.18632/oncotarget.18819

PMCID:: PMC5650331

Abstract Article PDF–3.2M

Select item 57377322.

Phase II trial of dacomitinib, a pan–human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification

Juan Manuel Sepúlveda-Sánchez, María Ángeles Vaz, Carmen Balañá, Miguel Gil-Gil, Gaspar Reynés, Óscar Gallego, María Martínez-García, Elena Vicente, María Quindós, Raquel Luque, Ana Ramos, Yolanda Ruano, Pedro Pérez-Segura, Manuel Benavides, Pilar Sánchez-Gómez, Aurelio Hernández-Laín

Neuro Oncol. 2017 Oct; 19(11): 1522–1531. Published online 2017 Jun 1. doi: 10.1093/neuonc/nox105

PMCID:: PMC5737732

Abstract Article PDF–685K

Select item 57221013.

Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis

Sergey V Roussakow

BMJ Open. 2017; 7(11): e017387. Published online 2017 Nov 3. doi: 10.1136/bmjopen-2017-017387

PMCID:: PMC5722101

Abstract Article PDF–2.6M

Select item 57160724.

Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab

Patrick Grossmann, Vivek Narayan, Ken Chang, Rifaquat Rahman, Lauren Abrey, David A Reardon, Lawrence H Schwartz, Patrick Y Wen, Brian M Alexander, Raymond Huang, Hugo J W L Aerts

Neuro Oncol. 2017 Nov; 19(12): 1688–1697. Published online 2017 May 11. doi: 10.1093/neuonc/nox092

PMCID:: PMC5716072

Abstract Article PDF–6.7M

Select item 56862645.

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study

Martin van den Bent, Hui K. Gan, Andrew B. Lassman, Priya Kumthekar, Ryan Merrell, Nicholas Butowski, Zarnie Lwin, Tom Mikkelsen, Louis B. Nabors, Kyriakos P. Papadopoulos, Marta Penas-Prado, John Simes, Helen Wheeler, Tobias Walbert, Andrew M. Scott, Erica Gomez, Ho-Jin Lee, Lisa Roberts-Rapp, Hao Xiong, Earle Bain, Peter J. Ansell, Kyle D. Holen, David Maag, David A. Reardon

Cancer Chemother Pharmacol. 2017; 80(6): 1209–1217. Published online 2017 Oct 26. doi: 10.1007/s00280-017-3451-1

PMCID:: PMC5686264

Abstract Article PDF–806K

Select item 56680416.

A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma

Isabel Arrillaga-Romany, Andrew S. Chi, Joshua E. Allen, Wolfgang Oster, Patrick Y. Wen, Tracy T. Batchelor

Oncotarget. 2017 Oct 3; 8(45): 79298–79304. Published online 2017 May 12. doi: 10.18632/oncotarget.17837

PMCID:: PMC5668041

Abstract Article PDF–814K

Select item 56584637.

Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis

Myra E. van Linde, Cyrillo G. Brahm, Philip C. de Witt Hamer, Jaap C. Reijneveld, Anna M. E. Bruynzeel, W. Peter Vandertop, Peter M. van de Ven, Michiel Wagemakers, Hiske L. van der Weide, Roelien H. Enting, Annemiek M. E. Walenkamp, Henk M. W. Verheul

J Neurooncol. 2017; 135(1): 183–192. Published online 2017 Jul 20. doi: 10.1007/s11060-017-2564-z

PMCID:: PMC5658463

Abstract Article PDF–951K

Select item 56546558.

Multicenter Phase I Dose Escalation Study of Hypofractionated Stereotactic Radiotherapy with Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma

Jennifer Clarke, Elizabeth Neil, Robert Terziev, Philip Gutin, Igor Barani, Thomas Kaley, Andrew B. Lassman, Timothy A. Chan, Josh Yamada, Lisa DeAngelis, Ase Ballangrud, Robert Young, Katherine S. Panageas, Kathryn Beal, Antonio Omuro

Int J Radiat Oncol Biol Phys. Author manuscript; available in PMC 2018 Nov 15.

Published in final edited form as: Int J Radiat Oncol Biol Phys. 2017 Nov 15; 99(4): 797–804. Published online 2017 Jun 30. doi: 10.1016/j.ijrobp.2017.06.2466

PMCID:: PMC5654655

Abstract Article PDF–1.0M

Select item 56543529.

Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma

Ulrik Lassen, Olivier L. Chinot, Catherine McBain, Morten Mau-Sørensen, Vibeke Andrée Larsen, Maryline Barrie, Patrick Roth, Oliver Krieter, Ka Wang, Kai Habben, Jean Tessier, Angelika Lahr, Michael Weller

Neuro Oncol. 2015 Jul; 17(7): 1007–1015. Published online 2015 Feb 9. doi: 10.1093/neuonc/nov019

PMCID:: PMC5654352

Abstract Article PDF–463K

Select item 575345410.

Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma – the GlioCave study (NOA 17 – ARO 2016/3 – DKTK ROG trial)

Christoph Straube, Hagen Scherb, Jens Gempt, Jan Kirschke, Claus Zimmer, Friederike Schmidt-Graf, Bernhard Meyer, Stephanie E. Combs

BMC Cancer. 2018; 18: 15. Published online 2018 Jan 3. doi: 10.1186/s12885-017-3928-7

PMCID:: PMC5753454

Abstract Article PDF–455K

Select item 564841111.

Combination Therapy with Low Copper Diet, Penicillamine and Gamma Knife Radiosurgery Reduces VEGF and IL-8 In Patients with Recurrent Glioblastoma

Alireza Feli, Shima Jazayeri, Mohammad Ali Bitaraf, Masoud Solaymani Dodaran, Karim Parastouei, Mohammad Javad Hosseinzadeh-Attar

Asian Pac J Cancer Prev. 2017; 18(7): 1999–2003. doi: 10.22034/APJCP.2017.18.7.1999

PMCID:: PMC5648411

Abstract Article PDF–284K

Select item 562659412.

Diffusion MRI phenotypes predict overall survival benefit from anti-VEGF monotherapy in recurrent glioblastoma: Converging evidence from phase II trials

Benjamin M. Ellingson, Elizabeth R. Gerstner, Marion Smits, Raymond Y. Huang, Rivka Colen, Lauren E. Abrey, Dana T. Aftab, Gisela M. Schwab, Colin Hessel, Robert J. Harris, Ararat Chakhoyan, Renske Gahrmann, Whitney B. Pope, Kevin Leu, Catalina Raymond, Davis C. Woodworth, John de Groot, Patrick Y. Wen, Tracy T. Batchelor, Martin J. van den Bent, Timothy F. Cloughesy

Clin Cancer Res. Author manuscript; available in PMC 2018 Oct 1.

Published in final edited form as: Clin Cancer Res. 2017 Oct 1; 23(19): 5745–5756. Published online 2017 Jun 27. doi: 10.1158/1078-0432.CCR-16-2844

PMCID:: PMC5626594

Abstract Article PDF–930K

Select item 558968313.

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

Alba A. Brandes, Gaetano Finocchiaro, Vittorina Zagonel, Michele Reni, Alessandra Fabi, Claudia Caserta, Alicia Tosoni, Marica Eoli, Giuseppe Lombardi, Matteo Clavarezza, Alexandro Paccapelo, Stefania Bartolini, Luigi Cirillo, Raffaele Agati, Enrico Franceschi

Oncotarget. 2017 Aug 15; 8(33): 55575–55581. Published online 2017 Feb 25. doi: 10.18632/oncotarget.15735

PMCID:: PMC5589683

Abstract Article PDF–734K

Select item 558198914.

Clinical Outcomes in Recurrent Glioblastoma with Bevacizumab therapy: An Analysis of the Literature

Matthew Tipping, Jens Eickhoff, H. Ian Robins

J Clin Neurosci. Author manuscript; available in PMC 2018 Oct 1.

Published in final edited form as: J Clin Neurosci. 2017 Oct; 44: 101–106. Published online 2017 Jul 12. doi: 10.1016/j.jocn.2017.06.070

PMCID:: PMC5581989

Abstract Article PDF–1.0M

Select item 556332015.

Multiparametric MRI and [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma

Comron Hassanzadeh, Yuan James Rao, Anupama Chundury, Jackson Rowe, Maria Rosana Ponisio, Akash Sharma, Michelle Miller-Thomas, Christina I. Tsien, Joseph E. Ippolito

Front Oncol. 2017; 7: 178. Published online 2017 Aug 18. doi: 10.3389/fonc.2017.00178

PMCID:: PMC5563320

Abstract Article PDF–681K

Select item 551462616.

A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma

Yazmin Odia, Joohee Sul, Joanna H Shih, Teri N Kreisl, John A Butman, Fabio M Iwamoto, Howard A Fine

CNS Oncol. 2016 Apr; 5(2): 59–67. Published online 2016 Feb 10. doi: 10.2217/cns-2015-0010

PMCID:: PMC5514626

Abstract Article PDF–2.0M

Select item 550345017.

Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response

Philipp Kickingereder, Michael Götz, John Muschelli, Antje Wick, Ulf Neuberger, Russell T Shinohara, Martin Sill, Martha Nowosielski, Heinz-Peter Schlemmer, Alexander Radbruch, Wolfgang Wick, Martin Bendszus, Klaus H Maier-Hein, David Bonekamp

Clin Cancer Res. Author manuscript; available in PMC 2017 Dec 1.

Published in final edited form as: Clin Cancer Res. 2016 Dec 1; 22(23): 5765–5771. Published online 2016 Oct 10. doi: 10.1158/1078-0432.CCR-16-0702

PMCID:: PMC5503450

Abstract Article PDF–1.3M

Select item 579653218.

Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus

Nusrat Jahan, Jae M. Lee, Khalid Shah, Hiroaki Wakimoto

Int J Cancer. Author manuscript; available in PMC 2018 Oct 15.

Published in final edited form as: Int J Cancer. 2017 Oct 15; 141(8): 1671–1681. Published online 2017 Jul 19. doi: 10.1002/ijc.30811

Expression of Concern in:: Int J Cancer. 2024 May 21

Correction in:: Int J Cancer. 2024 May 21

PMCID:: PMC5796532

Abstract Article PDF–1.9M

Select item 599044619.

Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation

Se-Hyuk Kim, Heon Yoo, Jong Hee Chang, Chae-Yong Kim, Dong Sup Chung, Se Hoon Kim, Sung-Hae Park, Youn Soo Lee, Seung Ho Yang

J Korean Med Sci. 2018 Jun 11; 33(24): e167. Published online 2018 May 10. doi: 10.3346/jkms.2018.33.e167

PMCID:: PMC5990446

Abstract Article PDF–978K

Select item 594832320.

¹¹C-methionine positron emission tomography for target delineation of recurrent glioblastoma in re-irradiation planning

Hidekazu Tanaka, Takahiro Yamaguchi, Kae Hachiya, Kazuhiro Miwa, Jun Shinoda, Masahide Hayashi, Shinichi Ogawa, Hironori Nishibori, Satoshi Goshima, Masayuki Matsuo

Rep Pract Oncol Radiother. 2018 May-Jun; 23(3): 215–219. Published online 2018 Apr 25. doi: 10.1016/j.rpor.2018.04.003

PMCID:: PMC5948323

Abstract Article PDF–1.0M

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 572

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity